Financial Contrast: Guardian Pharmacy Services (GRDN) vs. Its Competitors

Guardian Pharmacy Services (NYSE:GRDN) is one of 248 public companies in the “MED – DRUGS” industry, but how does it contrast to its peers? We will compare Guardian Pharmacy Services to similar companies based on the strength of its valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability.

Profitability

This table compares Guardian Pharmacy Services and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	-6.90%	-52.41%	-24.17%
Guardian Pharmacy Services Competitors	-19,762.45%	-97.72%	-18.38%

Earnings and Valuation

This table compares Guardian Pharmacy Services and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Guardian Pharmacy Services	$1.23 billion	-$87.29 million	-16.99
Guardian Pharmacy Services Competitors	$1.07 billion	$58.38 million	-2.06

Guardian Pharmacy Services has higher revenue, but lower earnings than its peers. Guardian Pharmacy Services is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Guardian Pharmacy Services and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0	0	3	0	3.00
Guardian Pharmacy Services Competitors	1291	3464	9394	355	2.61

Guardian Pharmacy Services currently has a consensus price target of $25.6667, indicating a potential downside of 0.63%. As a group, “MED – DRUGS” companies have a potential upside of 94.69%. Given Guardian Pharmacy Services’ peers higher probable upside, analysts plainly believe Guardian Pharmacy Services has less favorable growth aspects than its peers.

Institutional and Insider Ownership

43.8% of shares of all “MED – DRUGS” companies are owned by institutional investors. 63.7% of Guardian Pharmacy Services shares are owned by company insiders. Comparatively, 13.6% of shares of all “MED – DRUGS” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.